{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:03:28Z","timestamp":1794258208350,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72271-5","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:35:49Z","timestamp":1778481349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7844-7003","authenticated-orcid":false,"given":"Ching-Fei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7813-1292","authenticated-orcid":false,"given":"Heng-Huan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8001-129X","authenticated-orcid":false,"given":"Yun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-1890","authenticated-orcid":false,"given":"Yitao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2038-5863","authenticated-orcid":false,"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1430-7807","authenticated-orcid":false,"given":"Minghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1794-1360","authenticated-orcid":false,"given":"Jie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5275-6729","authenticated-orcid":false,"given":"Ying-Nai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1801-4964","authenticated-orcid":false,"given":"Cheng-Wei","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7633-286X","authenticated-orcid":false,"given":"Han","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-9978","authenticated-orcid":false,"given":"Anirban","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0172-7530","authenticated-orcid":false,"given":"Wantong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6231-9381","authenticated-orcid":false,"given":"Dihua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7003-6605","authenticated-orcid":false,"given":"Paul J.","family":"Chiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0616-2310","authenticated-orcid":false,"given":"Haoqiang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-4740","authenticated-orcid":false,"given":"Mien-Chie","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"72271_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ijc.24401","volume":"125","author":"D Duluc","year":"2009","unstructured":"Duluc, D. et al. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int J. Cancer 125, 367\u2013373 (2009).","journal-title":"Int J. Cancer"},{"key":"72271_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ijc.2910610119","volume":"61","author":"J Rodriguez-Villanueva","year":"1995","unstructured":"Rodriguez-Villanueva, J. & McDonnell, T. J. Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha. Int J. Cancer 61, 110\u2013114 (1995).","journal-title":"Int J. Cancer"},{"key":"72271_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1126\/science.1496401","volume":"257","author":"C Schindler","year":"1992","unstructured":"Schindler, C. et al. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257, 809\u2013813 (1992).","journal-title":"Science"},{"key":"72271_CR4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"72271_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ni0705-646","volume":"6","author":"MJ Smyth","year":"2005","unstructured":"Smyth, M. J. Type I interferon and cancer immunoediting. Nat. Immunol. 6, 646\u2013648 (2005).","journal-title":"Nat. Immunol."},{"key":"72271_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nature13904","volume":"515","author":"T Powles","year":"2014","unstructured":"Powles, T. et al. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. Nature 515, 558\u2013562 (2014).","journal-title":"Nature"},{"key":"72271_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1305133","volume":"369","author":"O Hamid","year":"2013","unstructured":"Hamid, O. et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N. Engl. J. Med. 369, 134\u2013144 (2013).","journal-title":"N. Engl. J. Med."},{"key":"72271_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","volume":"7","author":"DS Shin","year":"2017","unstructured":"Shin, D. S. et al. Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations. Cancer Discov. 7, 188\u2013201 (2017).","journal-title":"Cancer Discov."},{"key":"72271_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","volume":"167","author":"J Gao","year":"2016","unstructured":"Gao, J. et al. Loss of IFN-gamma pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy. Cell 167, 397\u2013404 (2016).","journal-title":"Cell"},{"key":"72271_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.trecan.2019.03.004","volume":"5","author":"A Herbert","year":"2019","unstructured":"Herbert, A. ADAR and immune silencing in cancer. Trends Cancer 5, 272\u2013282 (2019).","journal-title":"Trends Cancer"},{"key":"72271_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1101\/gr.219741.116","volume":"27","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers. Genome Res. 27, 1112\u20131125 (2017).","journal-title":"Genome Res."},{"key":"72271_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07824-4","volume":"9","author":"HS Gannon","year":"2018","unstructured":"Gannon, H. S. et al. Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells. Nat. Commun. 9, 5450 (2018).","journal-title":"Nat. Commun."},{"key":"72271_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41591-018-0302-5","volume":"25","author":"H Liu","year":"2019","unstructured":"Liu, H. et al. Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss. Nat. Med. 25, 95\u2013102 (2019).","journal-title":"Nat. Med."},{"key":"72271_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","volume":"565","author":"JJ Ishizuka","year":"2019","unstructured":"Ishizuka, J. J. et al. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Nature 565, 43\u201348 (2019).","journal-title":"Nature"},{"key":"72271_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","volume":"34","author":"T Conroy","year":"2023","unstructured":"Conroy, T. et al. Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 34, 987\u20131002 (2023).","journal-title":"Ann. Oncol."},{"key":"72271_CR16","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1128\/MCB.15.10.5376","volume":"15","author":"JB Patterson","year":"1995","unstructured":"Patterson, J. B. & Samuel, C. E. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell Biol. 15, 5376\u20135388 (1995).","journal-title":"Mol. Cell Biol."},{"key":"72271_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1006\/viro.1995.1370","volume":"210","author":"JB Patterson","year":"1995","unstructured":"Patterson, J. B. et al. Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. Virology 210, 508\u2013511 (1995).","journal-title":"Virology"},{"key":"72271_CR18","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1172\/JCI80011","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen, L. & Han, X. Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future. J. Clin. Invest. 125, 3384\u20133391 (2015).","journal-title":"J. Clin. Invest."},{"key":"72271_CR19","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1172\/JCI126022","volume":"129","author":"LC Chan","year":"2019","unstructured":"Chan, L. C. et al. IL-6\/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion. J. Clin. Invest. 129, 3324\u20133338 (2019).","journal-title":"J. Clin. Invest."},{"key":"72271_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21099-2","volume":"12","author":"R Yang","year":"2021","unstructured":"Yang, R. et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat. Commun. 12, 832 (2021).","journal-title":"Nat. Commun."},{"key":"72271_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/cancers9110157","volume":"9","author":"M Amrutkar","year":"2017","unstructured":"Amrutkar, M. & Gladhaug, I. P. Pancreatic cancer chemoresistance to gemcitabine. Cancers 9, 157 (2017).","journal-title":"Cancers"},{"key":"72271_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathol-011110-130303","volume":"6","author":"XH Tang","year":"2011","unstructured":"Tang, X. H. & Gudas, L. J. Retinoids, retinoic acid receptors, and cancer. Annu. Rev. Pathol. 6, 345\u2013364 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"72271_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96340-5","volume":"11","author":"A Osz","year":"2021","unstructured":"Osz, A., Lanczky, A. & Gyorffy, B. Survival analysis in breast cancer using proteomic data from four independent datasets. Sci. Rep. 11, 16787 (2021).","journal-title":"Sci. Rep."},{"key":"72271_CR24","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","volume":"184","author":"L Cao","year":"2021","unstructured":"Cao, L. et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell 184, 5031\u20135052 (2021).","journal-title":"Cell"},{"key":"72271_CR25","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.1016\/j.cell.2021.09.022","volume":"184","author":"BT Grunwald","year":"2021","unstructured":"Grunwald, B. T. et al. Spatially confined sub-tumor microenvironments in pancreatic cancer. Cell 184, 5577\u20135592 (2021).","journal-title":"Cell"},{"key":"72271_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00006676-200207000-00013","volume":"25","author":"E Albrechtsson","year":"2002","unstructured":"Albrechtsson, E., Ohlsson, B. & Axelson, J. The expression of retinoic acid receptors and the effects in vitro by retinoids in human pancreatic cancer cell lines. Pancreas 25, 49\u201356 (2002).","journal-title":"Pancreas"},{"key":"72271_CR27","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.1016\/S0021-9258(18)83713-9","volume":"264","author":"N Takahashi","year":"1989","unstructured":"Takahashi, N. & Breitman, T. R. Retinoic acid acylation (retinoylation) of a nuclear protein in the human acute myeloid leukemia cell line HL60. J. Biol. Chem. 264, 5159\u20135163 (1989).","journal-title":"J. Biol. Chem."},{"key":"72271_CR28","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.4049\/jimmunol.139.9.2977","volume":"139","author":"TJ Brown","year":"1987","unstructured":"Brown, T. J., Lioubin, M. N. & Marquardt, H. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells. J. Immunol. 139, 2977\u20132983 (1987).","journal-title":"J. Immunol."},{"key":"72271_CR29","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/ng.2414","volume":"44","author":"GI Rice","year":"2012","unstructured":"Rice, G. I. et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat. Genet. 44, 1243\u20131248 (2012).","journal-title":"Nat. Genet."},{"key":"72271_CR30","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.3389\/fimmu.2019.01763","volume":"10","author":"MM Lamers","year":"2019","unstructured":"Lamers, M. M., van den Hoogen, B. G. & Haagmans, B. L. ADAR1: \u201cEditor-in-Chief\u201d of cytoplasmic innate immunity. Front. Immunol. 10, 1763 (2019).","journal-title":"Front. Immunol."},{"key":"72271_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/2767-9764.CRC-21-0027","volume":"1","author":"KA Cottrell","year":"2021","unstructured":"Cottrell, K. A. et al. 8-azaadenosine and 8-chloroadenosine are not selective inhibitors of ADAR. Cancer Res. Commun. 1, 56\u201364 (2021).","journal-title":"Cancer Res. Commun."},{"key":"72271_CR32","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1091\/mbc.e05-06-0536","volume":"16","author":"JM Desterro","year":"2025","unstructured":"Desterro, J. M. et al. SUMO-1 modification alters ADAR1 editing activity. Mol. Biol. Cell 16, 5115\u20135126 (2025).","journal-title":"Mol. Biol. Cell"},{"key":"72271_CR33","doi-asserted-by":"publisher","first-page":"24974","DOI":"10.1074\/jbc.M116.737098","volume":"291","author":"L Li","year":"2016","unstructured":"Li, L. et al. Ubiquitin-dependent turnover of adenosine deaminase acting on RNA 1 (ADAR1) is required for efficient antiviral activity of type i interferon. J. Biol. Chem. 291, 24974\u201324985 (2016).","journal-title":"J. Biol. Chem."},{"key":"72271_CR34","doi-asserted-by":"publisher","first-page":"648491","DOI":"10.3389\/fphar.2021.648491","volume":"12","author":"J Lu","year":"2021","unstructured":"Lu, J. et al. Targeting ubiquitin-specific protease 7 (USP7) in cancer: a new insight to overcome drug resistance. Front. Pharm. 12, 648491 (2021).","journal-title":"Front. Pharm."},{"key":"72271_CR35","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.3390\/cancers14225539","volume":"14","author":"G Korenev","year":"2022","unstructured":"Korenev, G. et al. USP7 inhibitors in cancer immunotherapy: current status and perspective. Cancers 14, 5539 (2022).","journal-title":"Cancers"},{"key":"72271_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature24451","volume":"550","author":"AP Turnbull","year":"2017","unstructured":"Turnbull, A. P. et al. Molecular basis of USP7 inhibition by selective small-molecule inhibitors. Nature 550, 481\u2013486 (2017).","journal-title":"Nature"},{"key":"72271_CR37","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/jcp.22417","volume":"226","author":"LJ Gudas","year":"2011","unstructured":"Gudas, L. J. & Wagner, J. A. Retinoids regulate stem cell differentiation. J. Cell Physiol. 226, 322\u2013330 (2011).","journal-title":"J. Cell Physiol."},{"key":"72271_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-immunol-041015-055427","volume":"34","author":"A Larange","year":"2016","unstructured":"Larange, A. & Cheroutre, H. Retinoic acid and retinoic acid receptors as pleiotropic modulators of the immune system. Annu. Rev. Immunol. 34, 369\u2013394 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"72271_CR39","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/fsn3.961","volume":"7","author":"W Cui","year":"2019","unstructured":"Cui, W. et al. Vitamin A deficiency execrates Lewis lung carcinoma via induction of type 2 innate lymphoid cells and alternatively activates macrophages. Food Sci. Nutr. 7, 1288\u20131294 (2019).","journal-title":"Food Sci. Nutr."},{"key":"72271_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12630","volume":"7","author":"A Chronopoulos","year":"2016","unstructured":"Chronopoulos, A. et al. ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion. Nat. Commun. 7, 12630 (2016).","journal-title":"Nat. Commun."},{"key":"72271_CR41","doi-asserted-by":"publisher","first-page":"107942","DOI":"10.1016\/j.pharmthera.2021.107942","volume":"230","author":"N Takahashi","year":"2022","unstructured":"Takahashi, N. et al. Vitamin A in health care: suppression of growth and induction of differentiation in cancer cells by vitamin A and its derivatives and their mechanisms of action. Pharm. Ther. 230, 107942 (2022).","journal-title":"Pharm. Ther."},{"key":"72271_CR42","doi-asserted-by":"publisher","first-page":"661202","DOI":"10.3389\/fimmu.2021.661202","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Function of protein S-palmitoylation in immunity and immune-related diseases. Front. Immunol. 12, 661202 (2021).","journal-title":"Front. Immunol."},{"key":"72271_CR43","volume":"8","author":"Y Kuley-Bagheri","year":"2018","unstructured":"Kuley-Bagheri, Y. et al. Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL)). Cochrane Database Syst. Rev. 8, CD011960 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"72271_CR44","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1200\/JCO.1993.11.5.959","volume":"11","author":"JS Lee","year":"1993","unstructured":"Lee, J. S. et al. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors. J. Clin. Oncol. 11, 959\u2013966 (1993).","journal-title":"J. Clin. Oncol."},{"key":"72271_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1749-6632.1993.tb26185.x","volume":"691","author":"HCT Pitot","year":"1993","unstructured":"Pitot, H. C. T. et al. All-trans retinoic acid: a dose-seeking study in solid tumors. Ann. N. Y. Acad. Sci. 691, 250\u2013252 (1993).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"72271_CR46","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.celrep.2013.10.002","volume":"5","author":"IX Wang","year":"2013","unstructured":"Wang, I. X. et al. ADAR regulates RNA editing, transcript stability, and gene expression. Cell Rep. 5, 849\u2013860 (2013).","journal-title":"Cell Rep."},{"key":"72271_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100862","volume":"9","author":"S Dave","year":"2014","unstructured":"Dave, S. et al. Nuclear MEK1 sequesters PPARgamma and bisects MEK1\/ERK signaling: a non-canonical pathway of retinoic acid inhibition of adipocyte differentiation. PLoS One 9, e100862 (2014).","journal-title":"PLoS One"},{"key":"72271_CR48","doi-asserted-by":"publisher","first-page":"101571","DOI":"10.1016\/j.redox.2020.101571","volume":"34","author":"CC Fan","year":"2020","unstructured":"Fan, C. C. et al. EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis. Redox Biol. 34, 101571 (2020).","journal-title":"Redox Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72271-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72271-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72271-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:03:15Z","timestamp":1784188995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72271-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72271"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72271-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6297"}}